Results 121 to 130 of about 59,200 (224)

Opioids in breast cancer: Between analgesia and modulation of tumour progression

open access: yesBritish Journal of Pharmacology, EarlyView.
Preclinical investigations consistently demonstrate that activation of μ‐opioid receptors and δ‐opioid receptors promote proliferation, migration, angiogenesis, epithelial‐mesenchymal transition, acquisition of cancer stem cell phenotypes, and chemoresistance.
Marianna Ciwun   +2 more
wiley   +1 more source

Bacillus spore probiotics for alleviating functional constipation in children: a randomized, double-blind, placebo-controlled trial. [PDF]

open access: yesCommun Med (Lond)
Nguyen HTL   +9 more
europepmc   +1 more source

Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos   +16 more
wiley   +1 more source

Functional constipation in children

open access: yes, 2020
Functionele obstipatie is een veelvoorkomend chronisch probleem op de kinderleeftijd. Dit proefschrift is gericht op het onderzoeken van het meest optimale beleid voor kinderen met functionele obstipatie, en bespreekt nieuwe inzichten in de onderliggende oorzaak; diagnostische en therapeutische strategieën voor kinderen met (therapieresistente ...
openaire   +2 more sources

L‐VISP: LSTM Visualization for Interpretable Symptom Prediction in Patient Cohorts

open access: yesComputer Graphics Forum, EarlyView.
L‐VISP is a human‐machine solution that uses visual analytics for LSTM modelling in clinical research. L‐VISP uses custom visual encodings to make multiple LSTM variants interpretable, supporting a full range of analysis, from understanding model operations and evaluating performance to interpreting results in a clinical context.
C. Floricel   +6 more
wiley   +1 more source

Evidence‐ and consensus‐based guideline on lichen sclerosus

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary The German‐language, consensus‐ and evidence‐based S3 guideline on lichen sclerosus (LS) was developed based on the European “EuroGuiDerm Guideline on lichen sclerosus” under the leadership of the German Dermatological Society (DDG) and the German Society for Gynecology and Obstetrics (DGGG).
Gudula Kirtschig   +25 more
wiley   +1 more source

Home - About - Disclaimer - Privacy